Industry Verticals »

All Categories

Insights »

About TMR »

Transcriptomics Technologies Market

Transcriptomics Technologies Market (Microarrays, PCR, Gene Regulation and Next Generation Sequencing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Global Transcriptomics Technologies Market: Snapshot

The global transcriptomics technologies market is expected to experience noteworthy growth in the forthcoming years. The growing interest of pharmaceutical companies in the development of targeted and personalized therapeutics is creating a demand for the identification of disease-specific biomarkers. This trend is contributing significantly to the growth of the market. Moreover, the increasing investments in the research and development activities along with the continual improvement in the healthcare infrastructure is providing a substantial boost to the growth of the market.

The future of the global transcriptomics technologies market looks bright with the rising focus on the development of bioinformatics tools and services. The increasing research and development activities are creating a pressing need among corporate, academic, and research institutes to develop sophisticated and reliable software to manage the plethora of research data. Hence, there are immense opportunities for both software and life science companies to develop advanced bioinformatics tools. Owing to all these factors, the opportunity in the global transcriptomics technologies market was pegged at US$2.55 bn in 2015 and is poised to expand at a CAGR of 15.9% between 2013 and 2019, reaching US$4.62 bn by 2019.

Polymerase Chain Reaction to Take a Dive of Success Owing to their High Process Efficiency

On the basis of technology, polymerase chain reaction (PCR) will continue to lead the market in terms of revenue until 2019. Benefits offered by PCR such as high process efficiency, better precision, and greater amplification are boosting its uptake. Moreover, wider application areas along with versatility in approach and incessant product modification are catalyzing the growth of the segment.

The next generation sequencing (NGS) segment is likely to tread along a healthy growth track, expanding at a CAGR greater than 19.0% during the forecast period. Factors such as rapid technological advancements enabling the analysis of cellular transcriptome from several dimensions, expanding application areas of NGS, and the increasing outsourcing of sequencing technologies are propelling the growth of the segment.

Based on applications, drug discovery and research was the dominant segment in terms of revenue in 2015 and will maintain its leadership until 2019. The rigorous research and development initiatives in the field of genomics and proteomics are boosting the adoption of transcriptomics technologies in drug discovery and research. The segment is expected to expand at a significant CAGR of 18.2% during the same period.

North America to Lead Due to Rigorous Research and Development Activities Coupled with Increasing Investments

Geographically, the global transcriptomics technologies market will continue to be dominated by North America until 2019. The region is primarily driven by the presence of numerous biotech companies with well-established infrastructure and advanced technological platforms. The increasing investment from private organizations for transcriptomics research is assisting companies in the region in developing targeted therapeutics. Moreover, the presence of various academic and research institutes pursuing transcriptome studies is fuelling the growth of the region. The region will command 39% in the overall market revenue by 2019.

Asia Pacific is estimated to exhibit a CAGR of 18.0% during the same period. The tremendous growth of the region can be attributed to the consistent growth in the research and development activities in the field of life sciences. The rising trend of outsourcing clinical research and medical research, particularly in India and China, is fuelling the advancements in life sciences, thereby promoting the growth of the transcriptomics technologies market in the region.

Europe and Rest of the World are expected to rise at the similar pace during the forecast horizon. The leading players in the market are Affymetrix Inc., Agilent Technologies, F-Hoffmann La Roche Ltd., Illumina Inc., Life Technologies Corporation, and Thermo Fisher Scientific.

    Table of Content

     

    Chapter 1 Preface

    1.1 Report Description

    1.2 Market Segmentation

    1.3 Research Methodology

    1.4 List of Abbreviations

     

    Chapter 2 Executive Summary

     

    Chapter 3 Market Overview

    3.1 Introduction

          3.1.1 Market Potential of Transcriptomics Technologies

          3.1.2 Future Scenario of Transcriptomics

          3.1.3 Market Dynamics

    3.2 Market Drivers

          3.2.1 Technological Advancements

          3.2.2 Rising Preference for Personalized Medicine from both ends (Manufacturers and Consumers)

          3.2.3 Increasing Research and Development Investments

          3.2.4 Impact Analysis of Market Drivers

    3.3 Market Restraints

          3.3.1 Lack Of Efficient Data Analysis Tools

          3.3.2 Impact Analysis of Market Restraints

    3.4 Market Opportunities

          3.4.1 Focus on Development of Bioinformatics Tools and Services

    3.5 Porter’s Five Forces Analysis: Global Transcriptomics Technologies Market

          3.5.1 Bargaining Power Of Buyers

          3.5.2 Bargaining Power Of Suppliers

          3.5.3 Threat of Substitutes

          3.5.4 Threat of New Entrants

          3.5.5 Competitive Rivalry

    3.6 Market Attractiveness Analysis: Global Transcritpomics Technologies Market, By Geography

     

    Chapter 4 Global Transcriptomics Technologies Market, By Technology

    4.1 Introduction

    4.2 Microarrays

          4.2.1 Global Microarrays Market, Size and Forecast, 2011 - 2019 (USD Million)

          4.2.2 Polymerase Chain Reaction (PCR)

                   4.2.2.1 Global PCR Market, Size and Forecast, 2011 - 2019 (USD Million)

          4.2.3 Gene Regulation Technologies (RNA Interference Technology)

                  4.2.3.1 Global Gene Regulation Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

          4.2.4 Next Generation Sequencing (NGS)

                  4.2.4.1 Global Next Generation Sequencing Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

     

    Chapter 5 Global Transcriptomics Technologies Market, By Application

    5.1 Overview

    5.2 Clinical Diagnostics

          5.2.1 Global Clinical Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

    5.3 Drug Discovery And Research

          5.3.1 Global Drug Discovery and Research Market, Size and Forecast, 2011 - 2019 (USD Million)

    5.4 Bioinformatics

          5.4.1 Global Bioinformatics Market, Size and Forecast, 2011 - 2019 (USD Million)

    5.5 Comparative Transcriptome Studies

          5.5.1 Global Comparative Transcriptome Studies Market, Size and Forecast, 2011 - 2019 (USD Million)

     

    Chapter 6 Global Transcriptomics Technologies Market, By Geography

    6.1 Overview

          6.1.1 Global Transcriptomics Technologies Market, By Geography, Size and Forecast, 2011 – 2019 (USD Million)

          6.1.2 Comparative Analysis: Global Transcriptomics Technologies Market, By Geography, 2012 & 2019 (Value %)

    6.2 North America

          6.2.1 North America Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

    6.3 Europe

          6.3.1 Europe Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

    6.4 Asia-Pacific

          6.4.1 Asia-Pacific Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

    6.5 Rest of the World (Row)

          6.5.1 Row Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

     

    Chapter 7 Competitive Landscape

    7.1 Market Share By Key Players: Global Transcriptomics Technologies Market, 2012 (%)

     

    Chapter 8 Recommendations

    8.1 Collaboration with Academic and Research Institutes

    8.2 Focus on Imparting Education about Genomic Medicine

     

    Chapter 9 Company Profiles

    9.1 Affymetrix, Inc.

          9.1.1 Company Overview

          9.1.2 Financial Overview

          9.1.3 Product Portfolio

          9.1.4 Business Strategies

          9.1.5 Recent Developments

    9.2 Agilent Technologies, Inc.

          9.2.1 Company Overview

          9.2.2 Financial Overview

          9.2.3 Product Portfolio

          9.2.4 Business Strategies

          9.2.5 Recent Developments

    9.3 Bio-Rad Laboratories, Inc.

          9.3.1 Business Overview

          9.3.2 Financial Overview

          9.3.3 Product Portfolio

          9.3.4 Business Strategies

          9.3.5 Recent Developments

    9.4 Danaher Corporation

          9.4.1 Business Overview

          9.4.2 Financial Overview

          9.4.3 Product Portfolio

          9.4.4 Business Strategies

          9.4.5 Recent Developments

    9.5 F. Hoffmann-La Roche Ltd.

          9.5.1 Company Overview      

          9.5.2 Financial Overview

          9.5.3 Product Portfolio

          9.5.4 Business Strategies

          9.5.5 Recent Developments

    9.6 Illumina, Inc.

          9.6.1 Company Overview

          9.6.2 Financial Overview

          9.6.3 Product Portfolio

          9.6.4 Business Strategies

          9.6.5 Recent Developments

    9.7 Life Technologies Corporation

          9.7.1 Company Overview

          9.7.2 Financial Overview

          9.7.3 Product Portfolio

          9.7.4 Business Strategies

          9.7.5 Recent Developments

    9.8 LC Sciences, LLC

          9.8.1 Company Overview

          9.8.2 Financial Overview

          9.8.3 Product Portfolio

          9.8.4 Business Strategies

          9.8.5 Recent Developments

    9.9 Qiagen N.V.

          9.9.1 Company Overview

          9.9.2 Financial Overview

          9.9.3 Product Portfolio

          9.9.4 Business Strategies

          9.9.5 Recent Developments

    9.10 Sigma-Aldrich Corporation

          9.10.1 Company Overview

          9.10.2 Financial Overview

          9.10.3 Product Portfolio

          9.10.4 Business Strategies

          9.10.5 Recent Developments

    9.11 Thermo Fisher Scientific

          9.11.1 Company Overview

          9.11.2 Financial Overview

          9.11.3 Product Portfolio

          9.11.4 Business Strategies

          9.11.5 Recent Developments

    List of Tables

     

    TABLE 1 List of Abbreviations

    TABLE 2 Market Snapshot: Global Transcriptomics Technologies Market

    TABLE 3 Impact Analysis of Market Drivers

    TABLE 4 Impact Analysis of Market Restraints

    TABLE 5 Global Transcriptomics Technologies Market, By Technology, Size and Forecast, 2011-2019 (USD Million)

    TABLE 6 Global Transcriptomics Technologies Market, By Application, Size and Forecast, 2011-2019 (USD Million)

    TABLE 7 Global Transcriptomics Technologies Market, By Geography, Size and Forecast,     2011 – 2019(USD Million)

    List of Figures

     

    FIG. 1 Central Dogma : Transcriptomics Technologies Market

    FIG. 2 Transcriptomics Technologies: Market Segmentation

    FIG. 3 Global Transcriptomics Technologies Market, By Technology, 2012 (USD Million)

    FIG. 4 Porter’s Five Forces Analysis: Global Transcriptomics Technologies Market

    FIG. 5 Market Attractiveness Analysis: Global Transcriptomics Technologies Market, By Geography

    FIG. 6 Global Microarrays Market, Size and Forecast, 2011 - 2019 (USD Million)

    FIG. 7 Global PCR Market, Size and Forecast, 2011 - 2019 (USD Million)

    FIG. 8 Global Gene Regulation Market, Size and Forecast, 2011 - 2019 (USD Million)

    FIG. 9 Global Next Generation Sequencing Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

    FIG. 10 Global Clinical Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

    FIG. 11 Global Drug Discovery Market, Size and Forecast, 2011 - 2019 (USD Million)

    FIG. 12 Global Bioinformatics Market, Size and Forecast, 2011 - 2019 (USD Million)

    FIG. 13 Global Comparative Transcriptome Studies Market, Size and Forecast, 2011 - 2019 (USD Million)

    FIG. 14 Comparative Analysis: Global Transcriptomics Technologies Market, By Geography, 2012 & 2019 (Value %)

    FIG. 15 North America Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

    FIG. 16 Europe Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

    FIG. 17 Asia-Pacific Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

    FIG. 18 Row Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

    FIG. 19 Market Share Analysis: Global Transcriptomics Technologies Market, 2012 (%)

    FIG. 20 Affymetrix, Inc., Annual Revenue:  2010 – 2012 (USD Million)

    FIG. 21 Agilent Technologies, Inc., Annual Revenue: 2010 – 2012 (USD Million)

    FIG. 22 Bio-Rad Laboratories, Inc., Annual Revenue: 2010 – 2012 (USD Million)

    FIG. 23 Danaher Corporation, Annual Revenue: 2010 – 2012 (USD Million)

    FIG. 24 F. Hoffmann-La Roche Ltd., Annual Revenue: 2010 – 2012 (USD Million) (1 CHF = 1.09 USD)

    FIG. 25 Illumina, Inc., Annual Revenue: 2010 – 2012 (USD Million)

    FIG. 26 Life Technologies Corporation, Annual Revenue: 2010 – 2012 (USD Million)

    FIG. 27 Qiagen N.V., Annual Revenue: 2010 – 2012 (USD Million)

    FIG. 28 Sigma Aldrich Corporation, Annual Revenue: 2010 – 2012 (USD Million)

    FIG. 29 Thermo Fisher Scientific, Annual Revenue: 2010 – 2012 (USD Million)

Copyright © Transparency Market Research, Inc. All Rights reserved

Transcriptomics Technologies Market

Schedule a Call